Oxiran Successfully Passes GB/T 29490-2023 Intellectual Property Compliance Management System Surveillance Audit

2026/05/12

WUHAN, China – April 27, 2026 – Wuhan Oxiran Special Chemicals Co., Ltd. (hereinafter referred to as "Wuhan Oxiran"), a wholly-owned subsidiary of Jadechem, is pleased to announce that it has successfully passed the surveillance audit for the GB/T 29490-2023 Intellectual Property Compliance Management System.

The successful completion of this audit marks a significant milestone in the company’s ongoing commitment to standardizing its intellectual property (IP) framework and enhancing its global competitiveness.

Strengthening Risk Prevention and Core Competitiveness

The primary objective of this surveillance audit was to verify the effectiveness, compliance, and continuity of Wuhan Oxiran’s IP management system. By identifying potential areas for optimization, the audit process serves as a strategic tool to refine the company’s risk prevention capabilities and ensure that its IP management aligns with the highest national standards.

Audit Findings and Highlights

Following a comprehensive review, the audit team concluded that Wuhan Oxiran’s IP compliance management system is operating at a high level of efficiency. The auditors highlighted several key strengths:

• Strong Corporate Culture: A high level of IP compliance awareness was observed across all departments and levels of staff.

• Holistic Implementation: The company has successfully integrated IP considerations into the four critical pillars of creation and acquisition, management, utilization, and protection.

Future Outlook: Strategic IP Management

While confirming the system's robustness, the audit team also provided professional recommendations for future growth. Wuhan Oxiran intends to implement a more refined hierarchical IP management mechanism, which will focus on intensifying the protection of core technologies and maximizing the strategic value of its intellectual assets.

As a core subsidiary of Jadechem, Wuhan Oxiran continues to leverage its IP management system to drive innovation. By steadily improving its ability to create, apply, and protect intellectual property, the company remains dedicated to providing high-quality, technology-driven solutions for the specialty chemicals industry.

---

About Wuhan Oxiran Special Chemicals Co., Ltd.

Wuhan Oxiran Special Chemicals Co., Ltd., a wholly-owned subsidiary of Jadechem, specializes in the research, development, and production of high-performance fine chemicals. Through a focus on innovation and standardized management, the company serves as a key driver of Jadechem’s technological leadership in the global market.

• Previous: Jadechem Convenes May Business Kick...
• Next: None